HOME >> MEDICINE >> NEWS
NIAID forms network to tackle potentially fatal reaction to smallpox vaccine

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), today launched the Atopic Dermatitis and Vaccinia Network (ADVN), a nationwide research group that seeks to reduce the risk of eczema vaccinatum (EV), a severe and potentially deadly complication of smallpox immunization. EV occurs almost exclusively in people with a history of atopic dermatitis (AD), a chronic, itchy skin condition commonly referred to as eczema. While uncommon, EV can develop when AD patients are given the smallpox vaccine or come into close personal contact with people who recently received the vaccine. If untreated, EV can kill between 1 to 6 percent of those affected. In children younger than 2 years of age, EV has been estimated to kill up to 30 percent.

"Millions of Americans have a history of atopic dermatitis," says Anthony S. Fauci, M.D., director of NIAID. "Launching this network is an important step toward our goal of helping to protect everyone against the smallpox virus without the risk of life-threatening complications."

"Previous studies suggest that both innate and adaptive immunity are impaired in patients with atopic dermatitis, but the specific defects that increase the likelihood of eczema vaccinatum have yet to be explained," says Daniel Rotrosen, M.D., director of NIAID's Division of Allergy, Immunology and Transplantation. "The information generated by this network will improve our understanding of the immune responses of these patients and should greatly influence the design of a safer smallpox vaccine."

The ADVN comprises three integrated components: a clinical studies consortium, an animal studies consortium and a statistical and data coordinating center.

The ADVN Clinical Studies Consortium will, among other activities, seek to understand why people with AD have such severe reactions to smallpox vaccine by evaluating their immune responses after natural exposure to less harmf
'"/>

Contact: Paul Williams
pwilliams@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
19-May-2004


Page: 1 2

Related medicine news :

1. NIAID initiates trial of experimental avian flu vaccine
2. NIAID seeks applicants to lead clinical trials units for revamped HIV/AIDS networks
3. NIAID begins enrolling volunteers for novel HIV vaccine study
4. NIAID-sponsored clinical trial aims to boost flu vaccine supply
5. NIAID seeks applicants to lead revamped HIV/AIDS clinical trials networks
6. NIAID launches influenza genome sequencing project
7. NIAID launches program to improve medical tools against emerging infectious diseases
8. NIAID rotavirus vaccine licensed for commercialization
9. Second NIAID SARS vaccine candidate helps mice fend off SARS
10. NIAID vaccine protects against SARS virus infection in mice
11. NIAID Ebola vaccine enters human trial

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/9/2019)... ... 09, 2019 , ... On Monday, DOROT was featured in a New York ... New Yorker who recently faced homelessness. A call to 311 eventually connected her with ... a new home in an assisted-living facility in Brooklyn. , DOROT alleviates social isolation ...
(Date:11/7/2019)... ... ... Understanding UDI in EU Device Regulations, An FDAnews Webinar, Thursday, Nov. 21, ... and IV diagnostics sales in jeopardy? , It’s not a trick question. The last ... device and diagnostics makers simply aren’t prepared. , Not yet anyway. , Mark the ...
(Date:11/6/2019)... ... November 06, 2019 , ... ... University of Kentucky Research Foundation (UKRF) today announced they have entered into a ... hemp-derived product companies access to the broad resources of each organization to conduct ...
(Date:11/6/2019)... , ... November 06, 2019 ... ... of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene ... Executive Officer, John Chiminski, has received the inaugural CPhI Pharma Awards ‘Lifetime ...
(Date:11/5/2019)... ... 2019 , ... An October 2 article on Wicked Local Framingham ... nearly 20 years ago; she lost over 100 pounds and has remained petite ever ... and adult fat-shaming she endured prior to her procedure. Southern California healthcare group West ...
Breaking Medicine News(10 mins):
(Date:11/6/2019)... Ariz. (PRWEB) , ... November 06, 2019 , ... ... derived exosome product, NeoCyteXO. The exosome product offers significant advantages to all others ... or beat most current pricing being received. Call (888) 568-6909 for more information ...
(Date:11/5/2019)... ... November 05, 2019 , ... Modern Living Living with kathy ... Doctor of Holistic Medicine Heidi Reaganass and Head of Channel Partnerships and Media Relations ... cider vinegar. , Goli Nutrition is a nutrition company. Their goal is to ...
(Date:11/4/2019)... (PRWEB) , ... November 04, 2019 , ... An estimated ... D plan, will spend about $5,000 in 2019 ($416 month) just for Medicare premiums, ... “Medicare Part B and Medigap premiums are among the fastest growing costs in retirement, ...
Breaking Medicine Technology:
Cached News: